G. Berno

发表

Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs

L. Pucillo, A. Antinori, C. Perno, 2014, BMC Medical Genetics.

Analysis of HIV quasispecies and virological outcome of an HIV D+/R+ kidney–liver transplantation

G. D'offizi, M. Capobianchi, U. Visco-Comandini, 2022, Virology Journal.

SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods

E. Giombini, A. Garbuglia, C. Gruber, 2022, Pathogens.

Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy

A. Giacomelli, G. d’Ettorre, M. Capobianchi, 2022, Sexually Transmitted Infections.

Rapid and qualitative identification of SARS-CoV-2 mutations associated with variants of concern using a multiplex RT-PCR assay coupled with melting analysis

F. Carletti, A. Garbuglia, L. Fabeni, 2022, International Journal of Infectious Diseases.

Molecular Transmission Dynamics of Primary HIV Infections in Lazio Region, Years 2013–2020

M. Capobianchi, A. Antinori, V. Puro, 2021, Viruses.

Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen

Domenico Di Carlo, F. Ceccherini‐Silberstein, R. Bellagamba, 2016, The Journal of antimicrobial chemotherapy.

Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control

F. Ceccherini‐Silberstein, S. Alcaro, G. Costa, 2020, The Journal of antimicrobial chemotherapy.

Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.

C. Agrati, C. Gioia, E. Cimini, 2012, AIDS research and human retroviruses.

Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence

F. Ceccherini‐Silberstein, A. Antinori, R. Bellagamba, 2018, Scientific Reports.

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

Francesco Montella, Claudia Alteri, Vanni Borghi, 2017, Journal of Clinical Microbiology.

Interferon-α Improves Phosphoantigen-Induced Vγ9Vδ2 T-Cells Interferon-γ Production during Chronic HCV Infection

C. Agrati, C. Gioia, E. Cimini, 2012, PloS one.

Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia

F. Ceccherini‐Silberstein, A. Antinori, C. Mussini, 2015, Journal of Clinical Microbiology.

Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels.

F. Ceccherini‐Silberstein, E. Nicastri, A. Antinori, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients

A. Antinori, C. Perno, C. Gori, 2014, Journal of the International AIDS Society.

Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021

C. Castilletti, A. di Caro, M. Capobianchi, 2022, Frontiers in Medicine.

Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy

F. Ceccherini‐Silberstein, O. Turriziani, A. Antinori, 2019, Sexually Transmitted Infections.

Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice.

F. Ceccherini‐Silberstein, A. Antinori, C. Perno, 2022, Journal of Global Antimicrobial Resistance.

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.

F. Ceccherini‐Silberstein, E. Nicastri, C. Perno, 2015, The Journal of antimicrobial chemotherapy.

JCV-specific T-cells producing IFN-gamma are differently associated with PmL occurrence in HIV patients and liver transplant recipients.

C. Agrati, E. Cimini, V. Bordoni, 2015, The new microbiologica.

Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir.

F. Ceccherini‐Silberstein, S. Aquaro, C. Perno, 2020, The Journal of antimicrobial chemotherapy.

Virological and Serological Characterization of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination.

G. Ippolito, C. Castilletti, A. di Caro, 2021, medRxiv.

Intact provirus and integration sites analysis in acute HIV-1 infection and changes after one year of early antiviral therapy

A. Antinori, V. Puro, E. Girardi, 2022, Journal of virus eradication.

Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence

F. Ceccherini‐Silberstein, A. Antinori, R. Bellagamba, 2018, Scientific Reports.

Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs

L. Pucillo, A. Antinori, C. Perno, 2014, BMC Medical Genetics.

Virological response and resistance profile in highly treatment‐experienced HIV‐1‐infected patients switching to dolutegravir plus boosted darunavir in clinical practice

F. Ceccherini‐Silberstein, A. Antinori, C. Mussini, 2021, HIV medicine.

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.

Domenico Di Carlo, F. Ceccherini‐Silberstein, M. Andreoni, 2015, Journal of Antimicrobial Chemotherapy.

Virological characterization of HIV-1 RNA elements detected exclusively through the LTR region by the dual-target Aptima HIV-1 Quant Dx assay in a subset of positive patients.

R. Nardacci, E. Giombini, G. Rozera, 2023, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Molnupiravir increases SARS‐CoV‐2 genome diversity and complexity: A case‐control cohort study

F. Carletti, O. Butera, E. Giombini, 2024, Journal of medical virology.

Genomic and Epidemiologic Surveillance of SARS-CoV-2 in the Pandemic Period: Sequencing Network of the Lazio Region, Italy

O. Butera, P. Scognamiglio, E. Giombini, 2023, Viruses.

Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients

O. Butera, E. Giombini, Fabio Giovanni Tucci, 2023, Biomolecules.

HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015–21

F. Ceccherini‐Silberstein, C. Mussini, C. Perno, 2024, The Journal of antimicrobial chemotherapy.

Molecular Genotyping of Circulating Enterovirus in the Lazio Region from 2012 to 2023

S. Picone, L. Fabeni, M. Rueca, 2024, Viruses.